UMMS translational research featured in Sunday Telegram

Dr. Luzuriaga touts school’s 'real emphasis on innovation'

April 29, 2013

Katherine Luzuriaga, MD, professor of pediatrics and molecular medicine, and Craig Ceol, PhD, assistant professor of molecular medicine, discuss the ground-breaking translational research taking place at UMass Medical School in the April 28 Sunday Telegram.

"There's a real emphasis on innovation,” Dr. Luzuriaga told the Telegram in the article headlined, New Approach, Turning research into medical treatments. “We constantly want to look for ways to either make things faster or make things better because we know there are a lot of patients out there."

UMMS landed a prestigious $20 million Clinical and Translational Science Award from the National Institutes of Health to create an academic home for clinical and translational science across all five UMass campuses. Known as the UMass Center for Clinical and Translational Science, the award places UMass and the medical school's clinical partner, UMass Memorial Health Care, among an elite consortium of 60 nationally prominent academic medical centers working to move laboratory discoveries into treatments for patients, to engage communities in clinical research, and to train a new generation of researchers.

Read the full Telegram story on translational science here:

http://www.telegram.com/article/20130428/NEWS/304289982/1002/business